Histopathologic Characterization of Myocarditis Associated With Immune Checkpoint Inhibitor Therapy

Abstract

Context.— Cardiac complications of immune checkpoint inhibitor therapy are rare, but reports of myocarditis are increasing. The findings have been described in case reports as lymphocytic myocarditis, but its histopathology is underreported. Objective.— To review the histology of myocardial biopsy–proven cases of immune checkpoint–associated myocarditis and provide immunohistochemical characterization of the inflammatory infiltrate. Design.— We have encountered 6 patients with biopsy-proven myocarditis in conjunction with therapy using anti–programmed death receptor-1 (PD-1)/programmed death ligand-1 (PD-L1) agents with and without cytotoxic T-lymphocyte associated protein 4 (CTLA-4) inhibitors and characterized the histopathology and immune cell profile. Results.— The myocarditis was multifocal/diffuse, and characterized by a predominant CD163-positive histiocytic infiltrate, with an associated CD8+ and PD-1+ T-lymphocytic infiltrate, some of which were granzyme B positive. Cardiac myocytes showed immunoreactivity for PD-L1 in areas of injury, confirmed using 2 different anti–PD-L1 clones. Four of 6 patients recovered from their cardiac injury. One patient had residual tachycardia-bradycardia syndrome and 1 patient expired. Conclusions.— The diffuse lymphohistiocytic myocarditis associated with this therapy is relatively distinctive, and this diagnosis is strongly suggested based on the histopathologic findings in the correct clinical setting.

Immune checkpoint inhibitor treatment induces colitis with heavy infiltration of CD8 + T cells and an infiltration pattern that resembles ulcerative colitis

“…CD8 + T cells are the effectors of ICI anti-tumour effects, and high levels of CD8 + T cell infiltration in tumours before and during ICI treatment are associated with improved ICI efficacy [ 23 ]. The extent of CD8 + T cell mucosal infiltration in CIC reported in this study is comparable to heavy CD8 + T cell infiltration previously described in non-intestinal sites of autoimmune inflammation [ 24 – 27 ].…”

Immune Myocarditis Overlapping With Myasthenia Gravis Due to Anti-PD-1 Treatment for a Chordoma Patient: A Case Report and Literature Review

“…observed the same diffuse lymphohistiocytic myocarditis in 6 patients by EMB. The infiltrates were characterized by a population of PD-1–positive, CD8-positive, granzyme-B–positive T lymphocytes ( 18 ). They further found the immunoreactivity for PD-L1 in damaged area and proposed that the expression of PD-L1 on myocytes might be the key factor for avoiding self-targeting immune responses, which was in line with the second probable mechanism.…”

Immune checkpoint inhibitor-induced myocarditis in lung cancer patients: a case report of sintilimab-induced myocarditis and a review of the literature

“…Recent reports indicate that the relatively distinctive histologic feature of ICI-induced myocarditis is diffuse lymphocytic infiltration. This conclusion needs to be further verified due to the low number of endomyocardial biopsy (40).…”